Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide maintenance after chemotherapy for intermediate/high-risk B-cell lymphoma
ChiCTR2100053520Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lenalidomide in mature B-cell lymphoma, sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Overall Response Rate and Progression-Free Survival. Started Jul 2020; status: recruiting.
02
Drugs
lenalidomide
03
Conditions
mature B-cell lymphoma
Beyond the preview
Go deeper on ChiCTR2100053520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053520.